tykhr
sign in
free sign up
Vertex Pharmaceuticals Inc
Biotechnology
Healthcare
VRTX
260 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
381.59
52 week high
516.74
high
383.50
52 week low
0.00
low
376.00
growth
-18.33 %
previous Close
383.13
P/E ratio
94
market cap
118 B
div yield
0
usd
Mar 2025
qoq
revenue
2.77 B
-4.87 %
net incoming
646 M
-29.21 %
eps
4.06 %
2.01 %
eps surprise
-5.44 %
net profit margin
23.33 %
-8.00 %
operating incoming
630 M
-38.59 %
net change in cash
113 M
116.75 %
cash on hand
4.67 B
2.30 %
cost of revenue
363 M
-14.27 %
top